Amino acid replacement: V85M. V85 falls in the BIR1 domain.
G16039736A
V85M | Diap1-PA; V85M | Diap1-PB; V85M | Diap1-PC; V85M | Diap1-PD; V85M | Diap1-PE; V85M | Diap1-PF
V85M
Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change. V85 falls in the BIR1 domain.
As in wild type, thSL mutant bursCCAP neurons undergo programmed cell death shortly after eclosion.
Diap1SL is an enhancer of visible phenotype of Hsap\MAPTV337M.UAS, Scer\GAL4GMR.PF
Diap1SL is an enhancer of abnormal cell death phenotype of hidhs.PG
Diap1SL is an enhancer of abnormal cell death phenotype of hidGMR.PG
Diap1SL is a suppressor | partially of increased cell death phenotype of Scer\GAL4GMR.PF, rprUAS.cZa
Diap1SL is a suppressor of lethal phenotype of Scer\GAL4GMR.PF, rprUAS.cZa
Diap1SL is a suppressor | partially of visible phenotype of Scer\GAL4GMR.PF, rprUAS.cZa
Diap1SL is a suppressor of abnormal cell death phenotype of rprhs.PW
Diap1SL is a suppressor of abnormal cell death phenotype of grimGMR.PC
Diap1SL is a suppressor of abnormal cell death phenotype of rprGMR.PW
Diap1SL is a non-suppressor of lethal phenotype of Scer\GAL4GMR.PF, hidUAS.cZa
Diap1SL, Scer\GAL4GMR.PF is a non-suppressor of lethal phenotype of Scer\GAL4GMR.PF, grimUAS.cNa
Diap1SL is an enhancer of eye phenotype of Hsap\MAPTV337M.UAS, Scer\GAL4GMR.PF
Diap1SL is an enhancer of ommatidium phenotype of Hsap\MAPTV337M.UAS, Scer\GAL4GMR.PF
Diap1SL is a suppressor | partially of eye phenotype of Scer\GAL4GMR.PF, rprUAS.cZa
Diap1SL is a suppressor of eye phenotype of grimGMR.PC
Diap1SL is a non-suppressor of phenotype of Hsap\CDKN1AGMR.PH
Suppression of rprGMR.PW and grimGMR.PC in the eye is almost complete though enhancement of WGMR.PG is mild. Increases the viability of rprhs.PW flies threefold, but slightly enhances Whs.PG-induced death.
The rough eye phenotype caused by expression of Hsap\MAPTV337M.Scer\UAS under the control of Scer\GAL4GMR.PF is enhanced by thSL.
Behaves as a gain of function allele with respect to rpr- and grim-induced cell death. Behaves as a weak loss of function with respect to W-induced cell death: in the eye and the embryo W-induced cell death is not inhibited by thSL, it is enhanced.